127 related articles for article (PubMed ID: 25337223)
1. B-myb is a gene implicated in cell cycle and proliferation of breast cancer.
Tao D; Pan Y; Lu H; Zheng S; Lin H; Fang H; Cao F
Int J Clin Exp Pathol; 2014; 7(9):5819-27. PubMed ID: 25337223
[TBL] [Abstract][Full Text] [Related]
2. ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.
Kalashnikova EV; Revenko AS; Gemo AT; Andrews NP; Tepper CG; Zou JX; Cardiff RD; Borowsky AD; Chen HW
Cancer Res; 2010 Nov; 70(22):9402-12. PubMed ID: 20864510
[TBL] [Abstract][Full Text] [Related]
3. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
4. B-Myb Is Up-Regulated and Promotes Cell Growth and Motility in Non-Small Cell Lung Cancer.
Jin Y; Zhu H; Cai W; Fan X; Wang Y; Niu Y; Song F; Bu Y
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555007
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo analysis of B-Myb in basal-like breast cancer.
Thorner AR; Hoadley KA; Parker JS; Winkel S; Millikan RC; Perou CM
Oncogene; 2009 Feb; 28(5):742-51. PubMed ID: 19043454
[TBL] [Abstract][Full Text] [Related]
6. Central spindle proteins and mitotic kinesins are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cell lines and are potential targets for therapy.
Wolter P; Hanselmann S; Pattschull G; Schruf E; Gaubatz S
Oncotarget; 2017 Feb; 8(7):11160-11172. PubMed ID: 28061449
[TBL] [Abstract][Full Text] [Related]
7. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.
Yin Y; Cai J; Meng F; Sui C; Jiang Y
Cancer Biol Ther; 2018 Apr; 19(4):306-315. PubMed ID: 29561704
[TBL] [Abstract][Full Text] [Related]
8. B-Myb regulates snail expression to promote epithelial-to-mesenchymal transition and invasion of breast cancer cell.
Tao D; Pan Y; Jiang G; Lu H; Zheng S; Lin H; Cao F
Med Oncol; 2015 Jan; 32(1):412. PubMed ID: 25502082
[TBL] [Abstract][Full Text] [Related]
9. B-Myb promotes S-phase independently of its sequence-specific DNA binding activity and interacts with polymerase delta-interacting protein 1 (Pdip1).
Werwein E; Schmedt T; Hoffmann H; Usadel C; Obermann N; Singer JD; Klempnauer KH
Cell Cycle; 2012 Nov; 11(21):4047-58. PubMed ID: 23032261
[TBL] [Abstract][Full Text] [Related]
10. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
[TBL] [Abstract][Full Text] [Related]
11. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
[TBL] [Abstract][Full Text] [Related]
12. The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb.
Iness AN; Felthousen J; Ananthapadmanabhan V; Sesay F; Saini S; Guiley KZ; Rubin SM; Dozmorov M; Litovchick L
Oncogene; 2019 Feb; 38(7):1080-1092. PubMed ID: 30206359
[TBL] [Abstract][Full Text] [Related]
13. The role of MYB proto-oncogene like 2 in tamoxifen resistance in breast cancer.
Li X; Zhang X; Wu CC; Li PP; Fu YM; Xie LH; Sun SS; Zhou YY; Zhu BL
J Mol Histol; 2021 Feb; 52(1):21-30. PubMed ID: 33141360
[TBL] [Abstract][Full Text] [Related]
14. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
Mannefeld M; Klassen E; Gaubatz S
Cancer Res; 2009 May; 69(9):4073-80. PubMed ID: 19383908
[TBL] [Abstract][Full Text] [Related]
15. The Myb-MuvB Complex Is Required for YAP-Dependent Transcription of Mitotic Genes.
Pattschull G; Walz S; Gründl M; Schwab M; Rühl E; Baluapuri A; Cindric-Vranesic A; Kneitz S; Wolf E; Ade CP; Rosenwald A; von Eyss B; Gaubatz S
Cell Rep; 2019 Jun; 27(12):3533-3546.e7. PubMed ID: 31216474
[TBL] [Abstract][Full Text] [Related]
16. OGFOD1 is required for breast cancer cell proliferation and is associated with poor prognosis in breast cancer.
Kim JH; Lee SM; Lee JH; Chun S; Kang BH; Kwak S; Roe JS; Kim TW; Kim H; Kim WH; Cho EJ; Youn HD
Oncotarget; 2015 Aug; 6(23):19528-41. PubMed ID: 25909288
[TBL] [Abstract][Full Text] [Related]
17. Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.
Yuan SS; Hou MF; Hsieh YC; Huang CY; Lee YC; Chen YJ; Lo S
J Natl Cancer Inst; 2012 Oct; 104(19):1485-502. PubMed ID: 22914783
[TBL] [Abstract][Full Text] [Related]
18. The B-MYB transcriptional network guides cell cycle progression and fate decisions to sustain self-renewal and the identity of pluripotent stem cells.
Zhan M; Riordon DR; Yan B; Tarasova YS; Bruweleit S; Tarasov KV; Li RA; Wersto RP; Boheler KR
PLoS One; 2012; 7(8):e42350. PubMed ID: 22936984
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the cell cycle by B-Myb.
Bessa M; Joaquin M; Tavner F; Saville MK; Watson RJ
Blood Cells Mol Dis; 2001; 27(2):416-21. PubMed ID: 11259164
[TBL] [Abstract][Full Text] [Related]
20. Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor α.
Okumura F; Uematsu K; Byrne SD; Hirano M; Joo-Okumura A; Nishikimi A; Shuin T; Fukui Y; Nakatsukasa K; Kamura T
Mol Cell Biol; 2016 Jun; 36(12):1803-17. PubMed ID: 27090638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
